Cargando…
Cryptococcemia in a patient with COVID‐19: A case report
The authors urge clinicians to balance the use of Immunosuppressant drugs and tocilizumab for COVID‐19 patients to avoid the development of infections like Cryptococcemia, leading to death within 30 days.
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7869327/ https://www.ncbi.nlm.nih.gov/pubmed/33598258 http://dx.doi.org/10.1002/ccr3.3668 |